113 related articles for article (PubMed ID: 32278575)
1. Ten-year clinical outcomes for patients undergoing lower extremity endovascular interventions.
Katsuki T; Yamaji K; Hiramori S; Tomoi Y; Soga Y; Ando K
J Vasc Surg; 2020 Nov; 72(5):1626-1635.e3. PubMed ID: 32278575
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Clinical Outcomes between Endovascular Therapy with Self-Expandable Nitinol Stent and Femoral-Popliteal Bypass for Trans-Atlantic Inter-Society Consensus II C and D Femoropopliteal Lesions.
Okuno S; Iida O; Iida T; Takahara M; Yamaoka T; Kitano I; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Mano T
Ann Vasc Surg; 2019 May; 57():137-143. PubMed ID: 30500627
[TBL] [Abstract][Full Text] [Related]
3. The impact of inflow treatment for claudicants with both aortoiliac and femoropopliteal occlusive disease.
Maekawa T; Komori K; Kodama A; Banno H; Narita H; Sugimoto M
Surg Today; 2017 Mar; 47(3):293-300. PubMed ID: 27586013
[TBL] [Abstract][Full Text] [Related]
4. Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.
Torres-Blanco Á; Edo-Fleta G; Gómez-Palonés F; Molina-Nácher V; Ortiz-Monzón E
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):344-52. PubMed ID: 26202389
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia.
Tomoi Y; Soga Y; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamauchi Y; Miyashita Y; Tazaki J; Nobuyoshi M
Cardiovasc Interv Ther; 2013 Oct; 28(4):374-82. PubMed ID: 23756936
[TBL] [Abstract][Full Text] [Related]
6. Effect of Target Lesion Revascularization on Restenosis Lesions of the Superficial Femoral Artery without Recurred Symptoms after Endovascular Therapy.
Utsunomiya M; Takahara M; Fujihara M; Shiraki T; Kozuki A; Fukunaga M; Tan M; Yoshioka R; Tomoi Y; Mori S; Iwasaki Y; Sasaki S; Nakamura M
J Atheroscler Thromb; 2021 Jun; 28(6):643-655. PubMed ID: 32908114
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of sarpogrelate after endovascular treatment for femoropopliteal artery disease: ESPALIER study.
Soga Y; Shintani Y; Hamasaki T; Tomoi Y; Takaoka J; Suematsu N; Yokoi H; Ando K;
Cardiovasc Interv Ther; 2017 Oct; 32(4):325-332. PubMed ID: 27456034
[TBL] [Abstract][Full Text] [Related]
8. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
[TBL] [Abstract][Full Text] [Related]
9. New lesion after endovascular therapy of femoropopliteal lesions for intermittent claudication.
Katsuki T; Yamaji K; Soga Y; Iida O; Fujihara M; Kawasaki D; Ando K
Catheter Cardiovasc Interv; 2021 Sep; 98(3):E395-E402. PubMed ID: 34019325
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
11. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
[TBL] [Abstract][Full Text] [Related]
12. Open repair versus endovascular treatment of complex aortoiliac lesions in low risk patients.
Antonello M; Squizzato F; Bassini S; Porcellato L; Grego F; Piazza M
J Vasc Surg; 2019 Oct; 70(4):1155-1165.e1. PubMed ID: 30850298
[TBL] [Abstract][Full Text] [Related]
13. Spot stenting versus full coverage stenting after endovascular therapy for femoropopliteal artery lesions.
Tomoi Y; Soga Y; Takahara M; Fujihara M; Iida O; Kawasaki D; Ando K
J Vasc Surg; 2019 Oct; 70(4):1166-1176. PubMed ID: 30850285
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes and Cost Comparisons of Stent and Non-Stent Interventions in Infrainguinal Peripheral Artery Disease: Insights From the Excellence in Peripheral Artery Disease (XLPAD) Registry.
Banerjee S; Jeon-Slaughter H; Armstrong EJ; Bajzer C; Abu-Fadel M; Khalili H; Prasad A; Bou Dargham B; Kamath P; Addo T; Luna M; Gigliotti O; Foteh M; Cawich I; Kinlay S; Ali M; Ramanan B; Niazi K; Tsai S; Shammas NW; Brilakis ES
J Invasive Cardiol; 2019 Jan; 31(1):1-9. PubMed ID: 30611122
[TBL] [Abstract][Full Text] [Related]
15. Relationship between clinical outcomes and vessel size in endovascular therapy for femoropopliteal lesions.
Hiramori S; Soga Y; Iida O; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Ando K
J Vasc Surg; 2017 Jun; 65(6):1690-1697. PubMed ID: 28268108
[TBL] [Abstract][Full Text] [Related]
16. Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.
Miki K; Fujii K; Tanaka T; Yanaka K; Yoshihara N; Nishimura M; Sumiyoshi A; Horimatsu T; Imanaka T; Fukunaga M; Akahori H; Masuyama T; Ishihara M
J Endovasc Ther; 2020 Feb; 27(1):77-85. PubMed ID: 31948376
[No Abstract] [Full Text] [Related]
17. Angiographic flow velocity predicts lower limb outcomes after endovascular therapy: Application of the frame count method.
Ito N; Hishikari K; Yoshikawa H; Tsujihata S; Abe F; Kanno Y; Iiya M; Murai T; Hikita H; Takahashi A; Yonetsu T; Sasano T
Vasc Med; 2022 Feb; 27(1):39-46. PubMed ID: 34286654
[TBL] [Abstract][Full Text] [Related]
18. The Characteristics of In-Stent Restenosis After Drug-Eluting Stent Implantation in Femoropopliteal Lesions and 1-Year Prognosis After Repeat Endovascular Therapy for These Lesions.
Iida O; Takahara M; Soga Y; Hirano K; Yamauchi Y; Zen K; Kawasaki D; Nanto S; Yokoi H; Uematsu M;
JACC Cardiovasc Interv; 2016 Apr; 9(8):828-834. PubMed ID: 27101908
[TBL] [Abstract][Full Text] [Related]
19. Comparative Effectiveness Study of Drug-Eluting and Bare-Metal Peripheral Artery Stents in Endovascular Femoropopliteal Artery Revascularization.
Jeon-Slaughter H; Khalili H; Tsai S; Armstrong EJ; Shammas NW; Jawaid O; Lu H; Addo T; Gigliotti O; Abu-Fadel M; Banerjee S
J Invasive Cardiol; 2018 Oct; 30(10):373-379. PubMed ID: 30279293
[TBL] [Abstract][Full Text] [Related]
20. Incidence and its characteristics of repetition of reintervention after drug-eluting stent implantation for femoropopliteal lesion.
Iida O; Takahara M; Soga Y; Hirano K; Yamauchi Y; Zen K; Yokoi H; Uematsu M;
J Vasc Surg; 2016 Dec; 64(6):1691-1695.e1. PubMed ID: 27575807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
